Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$232,086
-$23,518 QoQ
Shares Held
1,837
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,833
of 2,266 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NWF Advisory Services Inc. holds $14,660,430 across 10 Drug Manufacturers - General names. GILD ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,825 | $3,227,283 | |
| 2 | LLY |
ELI LILLY & Co
|
2,136 | $2,561,982 | |
| 3 | JNJ |
Johnson & Johnson
|
9,493 | $2,410,937 | |
| 4 | AMGN |
Amgen Inc
|
5,766 | $2,087,983 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,785 | $1,899,872 | |
| 6 | PFE |
Pfizer Inc
|
38,937 | $937,602 | |
| 7 | AZN |
Astrazeneca PLC
|
3,332 | $631,813 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,255 | $360,413 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,086 | 1,837 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $255,604 | 1,834 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $224,982 | 1,833 | Shares | Sole | 2026-03-03 | |
| 2025-06-30 | $239,700 | 2,162 | Shares | Sole | 2025-09-09 | |
| 2025-03-31 | $208,749 | 1,863 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $206,446 | 2,235 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||